brief_summaries:
  description: clinical trial study protocol brief summary. if possible use this over detailed description.
  schema: |
    CREATE TABLE brief_summaries (
      nct_id VARCHAR NOT NULL,  -- clinical trial study unique id
      description TEXT,  -- clinical trial description / brief summary
      CONSTRAINT brief_summaries_pkey PRIMARY KEY (id), 
      CONSTRAINT brief_summaries_nct_id_fkey FOREIGN KEY(nct_id) REFERENCES studies (nct_id)
     );
  example: |
    /*
    3 rows from brief_summaries table:
    nct_id  description
    NCT01308385  Despite enormous progress insufficient postoperative pain management remains a frequent problem in t
    NCT05280444  The purpose of this real-world study is to evaluate the safety and efficacy of lipiodol-TACE with id
    NCT00372151  The aim of the proposed study is to investigate the efficacy and safety of add-on gamma-glutamylethy
    */

browse_conditions:
  description: condition studied in clinical trial. mesh term.
  schema: |
    CREATE TABLE browse_conditions ( 
     nct_id VARCHAR NOT NULL,  -- clinical trial study unique id
     mesh_term VARCHAR,  -- clinical condition
     downcase_mesh_term VARCHAR, -- downcase clinical condition 
     mesh_type VARCHAR, 
     CONSTRAINT browse_conditions_pkey PRIMARY KEY (id), 
     CONSTRAINT browse_conditions_nct_id_fkey FOREIGN KEY(nct_id) REFERENCES studies (nct_id)
    );
  example: |
    /*
    3 rows from browse_conditions table:
    nct_id  mesh_term  downcase_mesh_term  mesh_type
    319182123  NCT05825131  Connective Tissue Diseases  connective tissue diseases  mesh-ancestor
    319182124  NCT05825131  Metabolic Diseases  metabolic diseases  mesh-ancestor
    319182125  NCT05822752  Carcinoma  carcinoma  mesh-list
    */

browse_interventions:
  description: medical intervention assessed in clinical trial. mesh term.
  schema: |
    CREATE TABLE browse_interventions ( 
      nct_id VARCHAR NOT NULL, -- clinical trial study unique id
      mesh_term VARCHAR,  -- clinical intervention
      downcase_mesh_term VARCHAR, -- downcase clinical intervention
      mesh_type VARCHAR, 
      CONSTRAINT browse_interventions_pkey PRIMARY KEY (id), 
      CONSTRAINT browse_interventions_nct_id_fkey FOREIGN KEY(nct_id) REFERENCES studies (nct_id)
    );
  example: |
    /*
    3 rows from browse_interventions table:
    nct_id  mesh_term  downcase_mesh_term  mesh_type
    NCT00404274  Antiemetics  antiemetics  mesh-ancestor
    NCT00131027  Antimetabolites  antimetabolites  mesh-ancestor
    NCT00132119  Nalmefene  nalmefene  mesh-list
    */

countries:
  description: countries where the clinical trial takes place.
  schema: |
    CREATE TABLE countries ( 
      nct_id VARCHAR NOT NULL, -- clinical trial study unique id
      name VARCHAR, -- country name
      removed BOOLEAN, 
      CONSTRAINT countries_pkey PRIMARY KEY (id), 
      CONSTRAINT countries_nct_id_fkey FOREIGN KEY(nct_id) REFERENCES studies (nct_id)
    );
  example: |
    /*
    3 rows from countries table:
    nct_id  name  removed
    NCT02011217  Sweden  False
    NCT02011230  United States  False
    NCT01475955  United States  False
    */

design_group_interventions:
  description: patient group ids per clinical trial.
  schema: |
    CREATE TABLE design_group_interventions ( 
      nct_id VARCHAR NOT NULL, -- clinical trial study unique id
      design_group_id INTEGER, 
      intervention_id INTEGER, 
      CONSTRAINT design_group_interventions_pkey PRIMARY KEY (id), 
      CONSTRAINT design_group_interventions_design_group_id_fkey FOREIGN KEY(design_group_id) REFERENCES design_groups (id), 
      CONSTRAINT design_group_interventions_intervention_id_fkey FOREIGN KEY(intervention_id) REFERENCES interventions (id), 
      CONSTRAINT design_group_interventions_nct_id_fkey FOREIGN KEY(nct_id) REFERENCES studies (nct_id)
    );
  example: |
    /*
    3 rows from design_group_interventions table:
    nct_id  design_group_id  intervention_id
    NCT04294303  89068601  83864895
    NCT01419457  88886766  83678270
    NCT01419457  88886767  83678270
    */

designs:
  description: clinical trial design details.
  schema: |
    CREATE TABLE designs ( 
      nct_id VARCHAR NOT NULL, -- clinical trial study unique id
      allocation ENUM(Non-Randomized, N/A, Randomized), 
      intervention_model ENUM(Crossover Assignment, Sequential Assignment, Factorial Assignment, Single Group Assignment, Parallel Assignment), 
      observational_model ENUM(Other, Case-Only, Case-Crossover, Family-Based, Natural History, Case-Control, Defined Population, Cohort, Ecologic or Community), 
      primary_purpose ENUM(Diagnostic, Other, Supportive Care, Treatment, Device Feasibility, Educational/Counseling/Training, Health Services Research, Basic Science, Screening, Prevention), 
      time_perspective ENUM(Other, Prospective, Retrospective, Cross-Sectional), 
      masking ENUM(Quadruple, None (Open Label), Single, Double, Triple), 
      masking_description TEXT, -- clinical trials masking process
      intervention_model_description TEXT, -- clinical trial intervention intervention_model_description description
      subject_masked BOOLEAN, 
      caregiver_masked BOOLEAN, 
      investigator_masked BOOLEAN, 
      outcomes_assessor_masked BOOLEAN, 
      CONSTRAINT designs_pkey PRIMARY KEY (id), 
      CONSTRAINT designs_nct_id_fkey FOREIGN KEY(nct_id) REFERENCES studies (nct_id)
    );
  example: |
    /*
    3 rows from designs table:
    nct_id  allocation  intervention_model  observational_model  primary_purpose  time_perspective  masking  masking_description  intervention_model_description  subject_masked  caregiver_masked  investigator_masked  outcomes_assessor_masked
    NCT03990870  Randomized  Parallel Assignment    Treatment    Triple  None  None  True  None  True  True
    NCT01412476  None  None  Case-Control  None  Cross-Sectional  None  None  None  None  None  None  None
    NCT03986411  N/A  Single Group Assignment    Health Services Research    None (Open Label)  None  Mixed methods feasibility study. Three phases: Phase 1: Interviews Health car professionals, Phase 2  None  None  None  None
    */

detailed_descriptions:
  description: clinical trail protocol detailed and long description. If possible used brief description.
  schema: |
    CREATE TABLE detailed_descriptions ( 
      nct_id VARCHAR NOT NULL, -- clinical trial study unique id
      description TEXT, -- Long detailed description
      CONSTRAINT detailed_descriptions_pkey PRIMARY KEY (id), 
      CONSTRAINT detailed_descriptions_nct_id_fkey FOREIGN KEY(nct_id) REFERENCES studies (nct_id)
    );
  example: |
    /*
    3 rows from detailed_descriptions table:
    nct_id  description
    NCT02171936  This national study is the first study on the chronic pain and the social vulnerability, as well at 
    NCT05142488  After being informed about the study and potential risks, all participants giving written informed c
    NCT02172014  Comfort behavior scale consists of 7 components of alertness, calmness, respiratory response, crying
    */

drop_withdrawals:
  description: number of patient drop outs and withdrawals from clinical trial protocol.
  schema: |
    CREATE TABLE drop_withdrawals ( 
      nct_id VARCHAR NOT NULL, -- clinical trial study unique id
      result_group_id INTEGER, 
      ctgov_group_code VARCHAR, 
      period VARCHAR, 
      reason VARCHAR, -- reason for drop or withdrawal
      count INTEGER, -- number of patients
      drop_withdraw_comment VARCHAR, 
      reason_comment VARCHAR, 
      count_units INTEGER, 
      CONSTRAINT drop_withdrawals_pkey PRIMARY KEY (id), 
      CONSTRAINT drop_withdrawals_nct_id_fkey FOREIGN KEY(nct_id) REFERENCES studies (nct_id), 
      CONSTRAINT drop_withdrawals_result_group_id_fkey FOREIGN KEY(result_group_id) REFERENCES result_groups (id)
    );
  example: |
    /*
    3 rows from drop_withdrawals table:
    nct_id  result_group_id  ctgov_group_code  period  reason  count  drop_withdraw_comment  reason_comment  count_units
    NCT03409796  82724565  FG000  Overall Study  Adverse Event  2  None  None  None
    NCT03409796  82724566  FG001  Overall Study  Adverse Event  0  None  None  None
    NCT03409796  82724565  FG000  Overall Study  Other  0  None  None  None
    */

eligibilities:
  description: clinical trial eligibility criteria.
  schema: |
    CREATE TABLE eligibilities ( 
      nct_id VARCHAR NOT NULL, -- clinical trial study unique id
      sampling_method ENUM(Probability Sample, Non-Probability Sample), 
      gender ENUM(Male, Female, All), 
      minimum_age VARCHAR, -- e.g. 18 Years
      maximum_age VARCHAR, -- e.g. 50 Years
      healthy_volunteers ENUM(No, Accepts Healthy Volunteers), 
      population TEXT, -- population description
      criteria TEXT,  -- inclusion exclusion criteria
      gender_description TEXT, 
      gender_based BOOLEAN, 
      adult BOOLEAN, 
      child BOOLEAN, 
      older_adult BOOLEAN, 
      CONSTRAINT eligibilities_pkey PRIMARY KEY (id), 
      CONSTRAINT eligibilities_nct_id_fkey FOREIGN KEY(nct_id) REFERENCES studies (nct_id)
    );
  example: |
    /*
    3 rows from eligibilities table:
    nct_id  sampling_method  gender  minimum_age  maximum_age  healthy_volunteers  population  criteria  gender_description  gender_based  adult  child  older_adult
    NCT01308723  None  All  21 Years  N/A  No  None  Inclusion Criteria: Adult patients >/= 21 years of age Advanced or metastatic and/or unresectable h      None  None  True  False  True
    NCT02919670  None  All  18 Years  N/A  No  None  Inclusion Criteria: Participants must have histologically or cytologically confirmed Multiple Myelo      None  None  True  False  True
    NCT04529070  None  All  18 Years  N/A  No  None  **Patients must be able to get care at Nellis Air Force Base (a military installation) in order to p  None  None  True  False  True
    */

facilities:
  description: facility where the clinical trial take take place.
  schema: |
    CREATE TABLE facilities ( 
      nct_id VARCHAR NOT NULL, -- clinical trial study unique id
      status VARCHAR, 
      name VARCHAR, 
      city VARCHAR, 
      state VARCHAR, 
      zip VARCHAR, 
      country VARCHAR, 
      CONSTRAINT facilities_pkey PRIMARY KEY (id), 
      CONSTRAINT facilities_nct_id_fkey FOREIGN KEY(nct_id) REFERENCES studies (nct_id)
    );
  example: |
    /*
    3 rows from facilities table:
    nct_id  status  name  city  state  zip  country
    NCT06118151  None  Benchmark Research - Austin Site Number : 8400006  Austin  Texas  78705  United States
    NCT06118151  None  AES Austin Site Number : 8400021  Austin  Texas  78744  United States
    NCT06118151  None  Clinical Trials of Texas, Inc. Site Number : 8400012  San Antonio  Texas  78229  United States
    */

keywords:
  description: keywords associated to the clinical trial protocol
  schema: |
    CREATE TABLE keywords ( 
      nct_id VARCHAR NOT NULL, -- clinical trial study unique id
      name VARCHAR, -- keyword
      downcase_name VARCHAR, -- downcase keyword
      CONSTRAINT keywords_pkey PRIMARY KEY (id), 
      CONSTRAINT keywords_nct_id_fkey FOREIGN KEY(nct_id) REFERENCES studies (nct_id)
    );
  example: |
    /*
    3 rows from keywords table:
    nct_id  name  downcase_name
    NCT01982396  HIV  hiv
    NCT01982916  PAR  par
    NCT01987661  NIV  niv
    */

outcome_measurements:
  description: how is the outcome of the clinical trial measured. includes statistical analysis description.
  schema: |
    CREATE TABLE outcome_measurements ( 
      nct_id VARCHAR NOT NULL, -- clinical trial study unique id
      outcome_id INTEGER, 
      result_group_id INTEGER, 
      ctgov_group_code VARCHAR, 
      classification VARCHAR, 
      category VARCHAR, 
      title VARCHAR, 
      description TEXT, 
      units VARCHAR, 
      param_type VARCHAR, 
      param_value VARCHAR, 
      param_value_num NUMERIC, 
      dispersion_type VARCHAR, 
      dispersion_value VARCHAR, 
      dispersion_value_num NUMERIC, 
      dispersion_lower_limit NUMERIC, 
      dispersion_upper_limit NUMERIC, 
      explanation_of_na TEXT, 
      dispersion_upper_limit_raw VARCHAR, 
      dispersion_lower_limit_raw VARCHAR, 
      CONSTRAINT outcome_measurements_pkey PRIMARY KEY (id), 
      CONSTRAINT outcome_measurements_nct_id_fkey FOREIGN KEY(nct_id) REFERENCES studies (nct_id), 
      CONSTRAINT outcome_measurements_outcome_id_fkey FOREIGN KEY(outcome_id) REFERENCES outcomes (id), 
      CONSTRAINT outcome_measurements_result_group_id_fkey FOREIGN KEY(result_group_id) REFERENCES result_groups (id)
    )
  example: |
    /*
    3 rows from outcome_measurements table:
    nct_id  outcome_id  result_group_id  ctgov_group_code  classification  category  title  description  units  param_type  param_value  param_value_num  dispersion_type  dispersion_value  dispersion_value_num  dispersion_lower_limit  dispersion_upper_limit  explanation_of_na  dispersion_upper_limit_raw  dispersion_lower_limit_raw
    NCT01772004  49707268  82599299  OG000  Complete response (CR)  None  Efficacy Expansion Cohort (GC/GEJC, Third Line): Number of Participants With Confirmed Best Overall   Confirmed BOR was determined according to RECIST 1.1 and as adjudicated by an Independent Endpoint R  Participants  Count of Participants  2  2.0  None  None  None  None  None  None  None  None
    NCT01772004  49707268  82599299  OG000  Partial response (PR)  None  Efficacy Expansion Cohort (GC/GEJC, Third Line): Number of Participants With Confirmed Best Overall   Confirmed BOR was determined according to RECIST 1.1 and as adjudicated by an Independent Endpoint R  Participants  Count of Participants  5  5.0  None  None  None  None  None  None  None  None
    NCT00474253  49877831  82873706  OG001  Prior to transfer to recovery room  None  Number of Participants Experiencing General Muscle Weakness  The number of participants experiencing general muscle weakness was assessed by the investigator as   Participants  Count of Participants  3  3.0  None  None  None  None  None  None  None  None
    */

outcomes:
  description: clinical trial outcomes reported in the results section.
  schema: |
    CREATE TABLE outcomes ( 
      nct_id VARCHAR NOT NULL, -- clinical trial study unique id
      outcome_type Enum(Post-Hoc, Primary, Secondary, Other Pre-specified), 
      title TEXT, 
      description TEXT, -- outcomes description
      time_frame TEXT, 
      population TEXT, 
      anticipated_posting_date DATE, 
      anticipated_posting_month_year VARCHAR, 
      units VARCHAR, 
      units_analyzed VARCHAR, 
      dispersion_type VARCHAR, 
      param_type VARCHAR, 
      CONSTRAINT outcomes_pkey PRIMARY KEY (id), 
      CONSTRAINT outcomes_nct_id_fkey FOREIGN KEY(nct_id) REFERENCES studies (nct_id)
    )
  example: |
    /*
    3 rows from outcomes table:
    nct_id  outcome_type  title  description  time_frame  population  anticipated_posting_date  anticipated_posting_month_year  units  units_analyzed  dispersion_type  param_type
    NCT01964716  Primary  Number of Participants Reporting Systemic Events Within 5 Days After Dose 3 in MDV and SDS Group  Systemic events (any fever greater than or equal to [>=] 38.0 degrees Celsius [C], decreased appetit  Within 5 days after Dose 3 (Day 2 to Day 6) of infant series  Safety population included participants who received at least 1 dose of study vaccine. 'N' (number o  None  None  participants  None  None  Number
    NCT02534844  Secondary  Parts A/B: Change From Baseline in the Timed Up and Go (TUG) Test at Week 52  The TUG is a test of balance and risk for falls. This test measures the time taken by a participant   Baseline, Week 52  mITT population included all randomized participants who received at least one treatment. As per pla  None  None  seconds  None  Standard Deviation  Mean
    NCT00754572  Secondary  Percentage of Participants With a Response by Categorical DAS28 Responses According to The European   DAS28- based EULAR response criteria were used to measure individual response as none, good, and mod  Week 24  ITT Population; All participants with endpoint values collected at Week 24 were included in the anal  None  None  Percentage of Participants  None  95% Confidence Interval  Number
    */

reported_events:
  description: adverse events observed in a clinical trial.
  schema: |
    CREATE TABLE reported_events ( 
      nct_id VARCHAR NOT NULL, -- clinical trial study unique id
      result_group_id INTEGER, 
      ctgov_group_code VARCHAR, 
      time_frame TEXT, 
      event_type ENUM(other, serious), 
      default_vocab VARCHAR, 
      default_assessment VARCHAR, 
      subjects_affected INTEGER, 
      subjects_at_risk INTEGER, 
      description TEXT, --  adverse event description
      event_count INTEGER, 
      organ_system VARCHAR, 
      adverse_event_term VARCHAR, 
      frequency_threshold INTEGER, 
      vocab VARCHAR, 
      assessment VARCHAR, 
      CONSTRAINT reported_events_pkey PRIMARY KEY (id), 
      CONSTRAINT reported_events_nct_id_fkey FOREIGN KEY(nct_id) REFERENCES studies (nct_id), 
      CONSTRAINT reported_events_result_group_id_fkey FOREIGN KEY(result_group_id) REFERENCES result_groups (id)
    );
  example: |
    /*
    3 rows from reported_events table:
    nct_id  result_group_id  ctgov_group_code  time_frame  event_type  default_vocab  default_assessment  subjects_affected  subjects_at_risk  description  event_count  organ_system  adverse_event_term  frequency_threshold  vocab  assessment
    NCT03129100  82366267  EG001  Baseline, up to 128 weeks  serious  None  None  0  423  All randomized participants received at least one dose of study treatment. There are gender specific  0  Injury, poisoning and procedural complications  Pneumothorax traumatic  5  MedDRA 24.0  Systematic Assessment
    NCT00370552  82311312  EG001  Continuously from first to last dose of study drug (24 weeks)and within 30 days following last dose.  other  None  None  1  45  None  None  Skin and subcutaneous tissue disorders  Nail dystrophy  5  MedDRA 12.1  Systematic Assessment
    NCT03484923  82494147  EG002  On-treatment: from first dose to 30 days post-treatment, up to 49/24 months (randomized/non-randomiz  other  None  None  None  0  Any sign or symptom that occurs during the conduct of the trial and safety follow-up. Deaths in the   None  Investigations  SARS-CoV-2 test negative  5  MedDRA (25.1)  Systematic Assessment
    */

sponsors:
  description: clinical trial sponsor.
  schema: |
    CREATE TABLE sponsors (
      nct_id VARCHAR NOT NULL, -- clinical trial study unique id
      agency_class VARCHAR, 
      lead_or_collaborator VARCHAR, 
      name VARCHAR, 
      CONSTRAINT sponsors_pkey PRIMARY KEY (id), 
      CONSTRAINT sponsors_nct_id_fkey FOREIGN KEY(nct_id) REFERENCES studies (nct_id)
    );
  example: |
    /*
    3 rows from sponsors table:
    nct_id  agency_class  lead_or_collaborator  name
    NCT02155296  OTHER  lead  RAND
    NCT02155296  NIH  collaborator  Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
    NCT05020288  OTHER  lead  Shandong University
    */

studies:
  description: general information regarding a clinical trial protocol.
  schema: |
    CREATE TABLE studies (
      nct_id VARCHAR NOT NULL, -- clinical trial study unique id
      study_type ENUM(Observational [Patient Registry], Interventional, Expanded Access, Observational),  
      baseline_population TEXT, 
      brief_title TEXT,
      official_title TEXT, 
      overall_status ENUM(Approved for marketing, Active, not recruiting, Completed, Enrolling by invitation, No longer available, Not yet recruiting, Recruiting, Suspended, Temporarily not available, Terminated, Unknown status, Withdrawn, Withheld), 
      phase ENUM(Early Phase 1, Phase 1, Phase 1/Phase 2, Phase 2, Phase 2/Phase 3, Phase 3, Phase 4, Not Applicable)
      enrollment INTEGER, -- Number of patients enrolled into the clinical trial study
      source VARCHAR, 
      limitations_and_caveats VARCHAR, 
      why_stopped VARCHAR, 
      has_expanded_access BOOLEAN, , 
      biospec_retention ENUM(None Retained, Samples With DNA, Samples Without DNA), 
      biospec_description TEXT, 
      CONSTRAINT studies_nct_id_fkey FOREIGN KEY(nct_id) REFERENCES studies (nct_id)
    );
  example: |
    /*
    3 rows from studies table:
    nct_id  study_type  baseline_population  brief_title  official_title  overall_status  phase  enrollment  source  limitations_and_caveats  why_stopped  biospec_retention  biospec_description
    NCT06191848  Interventional  NULL  Subcutaneous Tirzepatide Once-weekly in Patients With Obesity and Knee Osteoarthritis (STOP KNEE-OA)  Effect of Subcutaneous Tirzepatide Once-weekly in Patients With Obesity and Knee Osteoarthritis (STOP KNEE-OA): A Randomized, Double-Blind, Placebo-Controlled Trial  Not yet recruiting  Phase 4  352  University of Melbourne  NULL  NULL  NULL  NULL
    NCT06190795  Interventional  NULL  A Smartphone Application for a Self-directed Upper Limb Therapy After Stroke  Feasibility and Effectiveness of AI-powered Interactive Smartphone Application for a Self-directed Upper Limb Therapy Implementation After Stroke  Not yet recruiting  Not Applicable  80  Tan Tock Seng Hospital  NULL  NULL  NULL  NULL
    NCT02732574  Interventional  NULL  Oscillating Positive Expiratory Pressure (OPEP) Therapy in High Risk Patients Following Cardiac Surgery  The Effectiveness of Oscillating Positive Expiratory Pressure (OPEP) Therapy in High Risk Patients Following Cardiac Surgery Surgery: A Randomized Clinical Trial  Unknown status  Not Applicable  162  Lawson Health Research Institute  NULL  NULL  NULL  NULL
    */
